Piperlongumine conquers temozolomide chemoradiotherapy resistance to achieve immune cure in refractory glioblastoma via boosting oxidative stress-inflamation-CD8+-T cell immunity - Feng Liu; Qian Zhou; Hai-feng Jiang; Ting-ting Zhang; Cheng Miao; Xiao-hong Xu; Jia-xing Wu; Song-lin Yin; Shi-jie Xu; Jing-yi Peng; Pan-pan Gao; Xuan Cao; et al. (Journal of Experimental & Clinical Cancer Research, 2023)